Intravitreal Bevacizumab for Choroidal Neovascularization Attributable to Pathological Myopia: One-Year Results
- 9 September 2008
- journal article
- research article
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 147 (1), 94-100.e1
- https://doi.org/10.1016/j.ajo.2008.07.017
Abstract
No abstract availableFunding Information
- Ministry of Education, Culture, Sports, Science and Technology
This publication has 27 references indexed in Scilit:
- Complications in patients after intravitreal injection of bevacizumabActa Ophthalmologica, 2008
- Intravitreal Bevacizumab (Avastin) for Myopic Choroidal NeovascularizationOphthalmology, 2007
- Intravitreal injection of bevacizumab for choroidal neovascularisation associated with pathological myopiaBritish Journal of Ophthalmology, 2007
- Intravitreal bevacizumab (Avastin) as treatment for subfoveal choroidal neovascularisation secondary to pathological myopiaBritish Journal of Ophthalmology, 2007
- Retinal Pigment Epithelial Tear After Intravitreal Bevacizumab InjectionAmerican Journal of Ophthalmology, 2006
- The International Intravitreal Bevacizumab Safety Survey: using the internet to assess drug safety worldwideBritish Journal of Ophthalmology, 2006
- Intravitreal Injection of Bevacizumab (Avastin) as Adjunctive Treatment of Proliferative Diabetic RetinopathyAmerican Journal of Ophthalmology, 2006
- Choroidal Neovascularization in Pathologic Myopia: Three-Year Results After Photodynamic TherapyAmerican Journal of Ophthalmology, 2005
- Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopiaOphthalmology, 2003
- PHOTOCOAGULATION SCAR EXPANSION AFTER LASER THERAPY FOR CHOROIDAL NEOVASCULARIZATION IN DEGENERATIVE MYOPIARetina, 1990